Search for a clinical trial
Other search option(s)
36 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
EWING2008: Phase 3, Open Label, Multi-centre, Randomised Controlled International Study in Ewing Sarcoma - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
WIEN
REGO-SARC: Activity and Safety of Regorafenib in Patients With Metastatic Soft Tissue Sarcoma Previously Treated With Anthracycline-based Chemotherapy: a Multinational, Randomized, Phase II, Placebo-controlled Trial - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE
EWING2008: Phase 3, Open Label, Multi-centre, Randomised Controlled International Study in Ewing Sarcoma - BE
Institution: Information not provided - BE
FINLAND
Finland
HELSINKI
rEECur: International randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma -FI
HUS - Helsinki University Hospital
Division of Pediatric Hematology-Oncology and Stem Cell Transplantation
GERMANY
Bayern
ERLANGEN
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma -DE-
Universitätsmedizin Erlangen
Universitätsklinikum Erlangen
GERMANY
Berlin
BERLIN
PazoQol: Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib - a Randomized, Controlled Trial -DE-
Helios Klinikum Emil von Behring
Klinik für Onkologie
GERMANY
Hessen
FRANKFURT AM MAIN
OlaReDo: Efficacy of Olaratumab and Rechallenge With Doxorubicin in Anthracycline Pretreated, Advanced Soft Tissue Sarcoma Patients. An Exploratory Phase-II Study
Krankenhaus Nordwest GmbH
Institut für Klinisch-Onkologische Forschung
SPAIN
Andalucía
SEVILLA
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
Hospital Universitario Virgen del Rocío
MUsculoSkeletal Tumor Board of Excellence Sevilla (MUSTBE SEVILLA)
SPAIN
Andalucía
SEVILLA
ANNOUNCE 2: A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma - ES
Hospital Universitario Virgen del Rocío
Unidad de Oncología Médica, Oncología Radioterápica y Radiofísica
SPAIN
Cataluña
BADALONA
GEIS-51: Phase II multicenter trial of palbociclib in second line of advanced sarcomas with CDK4 overexpression - ES
ICO Badalona - Hospital Germans Trias i Pujol
Servicio de Oncología Médica
SPAIN
Cataluña
BARCELONA
ANNOUNCE 2: A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma - ES
Hospital Universitari Vall d'Hebron
Servicio de Oncología Médica
SPAIN
Madrid
MADRID
ANNOUNCE 2: A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma - ES
Hospital Universitario 12 de Octubre
Servicio de Oncología Médica
SPAIN
Madrid
MADRID
ANNOUNCE 2: A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma - ES
Hospital Universitario La Paz
Servicio de Oncología Médica
SWITZERLAND
Suisse Romande
ADDRESS: NOT PROVIDED - CH
ANNOUNCE 2: A Phase 1b (Open-Label) / Phase 2 (Randomized,Double-Blinded) Study Evaluating Gemcitabine andDocetaxel With or Without Olaratumab in the Treatment ofAdvanced Soft Tissue Sarcoma -GB
Institution: Information not provided - CH
SWITZERLAND
Suisse Romande
ADDRESS: NOT PROVIDED - CH
PazoQol: Quality of life in patients with non-adipocyte soft tissue sarcoma underpalliative chemotherapy or pazopanib - a randomized, controlled trial - CH
Institution: Information not provided - CH
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
An Open-Label, Multicohort, Phase II Study of Atezolizumab in Advanced Solid Tumors (Phase 2) - AT
Institution: Information not provided - AT
AUSTRIA
WIEN
WIEN
A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Malignancies - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie
AUSTRIA
WIEN
WIEN
ANNOUNCE: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin Plus Olaratumab Versus Doxorubicin Plus Placebo in Patients With Advanced or Metastatic Soft Tissue Sarcoma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Onkologie
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
An Open-label, Multi-center, Randomized Study of the Safety and Effect on Event-free Survival of Bevacizumab in Combination With Standard Chemotherapy in Childhood and Adolescent Patients With Metastatic Rhabdomyosarcoma and Non-rhabdomyosarcoma Soft Tissue Sarcoma (Phase II) - FR
Institution: Information not provided - FR
FRANCE
AUVERGNE-RHONE-ALPES
LYON
Multicenter phase I/II study of continuous dosing of Sunitinib in non-GIST sarcomas with concomitant radiation therapy.
CLCC Léon Bérard
Radiothérapie
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
RADIOSARP : A Phase Ib Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
TRAMUNE : Trabectedin Combined With Durvalumab (MEDI4736) in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas : A Phase Ib Study
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
TARMIC : Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly trabectedin combined with Metronomic Cyclophosphamide in Patients with Advanced Pretreated Soft-tissue Sarcomas. A Phase I/II study from the French Sarcoma Group
CLCC Institut Bergonié
Département d'oncologie médicale - Sarcomes
GERMANY
Baden-Württemberg
HEIDELBERG
Retro-Ion: Neoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion Prospektive Randomisierte Phase-II-Studie
Neurologische Universitätsklinik Heidelberg
Klinik für Radioonkologie und Strahlentherapie
GERMANY
Nordrhein-Westfalen
KÖLN
EORTC 62072 (PALETTE) - A randomized, double blind phase III trial of Pazopanib versus Placebo in patients with Soft Tissue Sarcoma whose disease has progressed during or following prior therapy - DE
Universitätsklinikum Köln
Klinik I für Innere Medizin - AG Prof. Wendtner
HUNGARY
Észak-Alföld
DEBRECEN
A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma
Debreceni Egyetem Klinikai Központ Onkológiai Intézet
Institute of Oncology
SPAIN
Comunidad Valenciana
VALENCIA
ANNOUNCE: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma - ES
Hospital Universitario y Politécnico La Fe
Servicio de Oncología Médica
SPAIN
Madrid
MADRID
Randomized, double-blind, 3-arm trial to evaluate the impact of blood loss following administration of three tranexamic acid regimens in patients undergoing bone or soft tissue sarcomas (Phase III) - ES
IdiPAZ - Instituto de Investigación Sanitaria del Hospital Universitario La Paz
Unidad Central de Investigación Clínica y Ensayos Clínicos del Hospital La Paz
SWITZERLAND
Suisse Alémanique
ST. GALLEN
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial
Kantonsspital St. Gallen
Klinik für Medizinische Onkologie und Hämatologie; Klinik für Neurologie
SWITZERLAND
Suisse Romande
LAUSANNE
NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma. A Multicenter Open-label Single Arm Phase Ib/IIa Trial
Centre Hospitalier Universitaire Vaudois CHUV
Département d'oncologie
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
STEP: Sorafenib Long Term Extension Program - BE
Cliniques universitaires Saint-Luc - UCLouvain
Pneumologie_Oncologie thoracique
Multinational clinical trial(s)
GERMANY
Baden-Württemberg
ULM
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
ANNOUNCE 2: A Phase 1b (Open-Label) / Phase 2 (Randomized,Double-Blinded) Study Evaluating Gemcitabine andDocetaxel With or Without Olaratumab in the Treatment ofAdvanced Soft Tissue Sarcoma
Institution: Information not provided - US
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US
A Phase 1b Trial to Assess the Modulation of Biological Markers in Patients With Potentially Resectable Soft Tissue Sarcoma Treated With Olaratumab Monotherapy Followed by Olaratumab Plus Doxorubicin Combination Therapy
Institution: Information not provided - US
UNITED STATES
Kansas
LAWRENCE
A Multicenter Phase 1, Open-Label Study of DCC-2618 to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced Malignancies
Deciphera Pharmaceuticals, LLC.
UNITED STATES
Washington
ADDRESS: NOT PROVIDED - US